Guerreiro Vanessa, Maia Isabel, Neves João Sérgio, Salazar Daniela, Ferreira Maria João, Mendonça Fernando, Silva Maria Manuel, Borges-Canha Marta, Viana Sara, Costa Cláudia, Pedro Jorge, Varela Ana, Lau Eva, Freitas Paula, Carvalho Davide
Departamento de Endocrinologia, Diabetes E Metabolismo, Centro Hospitalar Universitário São João, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.
Faculdade de Medicina, Universidade Do Porto, Porto, Portugal.
Diabetol Metab Syndr. 2022 Jul 6;14(1):91. doi: 10.1186/s13098-022-00865-2.
One hour plasma glucose concentration (1hPG) during an oral glucose tolerance test (OGTT) may be an alternative to 2-h plasma glucose concentration (2hPG) in the identification of individuals at increased risk of hyperglycaemia, although its role is not fully understood.
We aim to investigate the relationship of these measures with other glucose parameters, as well as their relationship with cardiometabolic risk markers and the level of agreement for prediabetes mellitus diagnosis, in a sample of patients with morbid obesity.
We retrospectively evaluated 656 patients with morbid obesity without diagnosed diabetes. To define prediabetes with 2hPG, 2022 American Diabetes Association guidelines criteria were used, while for 1hPG, glucose ≥ 155 mg/dL was considered. Cohen's Kappa coefficient was used to assess the agreement between both measures of prediabetes mellitus diagnosis.
A Cohen's Kappa coefficient of 0.405 (p < 0.001) was obtained. The 1hPG were positively correlated with homeostatic model assessment for insulin resistance (HOMA-IR) (ρ = 0.281, p < 0.001), fasting plasma glucose (FPG) (ρ = 0.581, p < 0.001), glycated haemoglobin (Hb1AC) (ρ = 0.347, p < 0.001) and were negatively correlated with homeostatic model assessment for cell-β function (HOMA-β) (ρ = -0.092, p = 0.018). 2hPG were also correlated with the same parameters, except for HOMA-β.
A fair agreement between 1 and 2hPG was verified. 1hPG criteria may be a useful indicator of β-cell dysfunction and insulin resistance in patients with morbid obesity without diabetes diagnosis.
口服葡萄糖耐量试验(OGTT)期间的1小时血浆葡萄糖浓度(1hPG)可能是识别高血糖风险增加个体的2小时血浆葡萄糖浓度(2hPG)的替代指标,尽管其作用尚未完全明确。
我们旨在研究这些指标与其他血糖参数的关系,以及它们与心脏代谢风险标志物的关系和在病态肥胖患者样本中糖尿病前期诊断的一致性水平。
我们回顾性评估了656例未诊断糖尿病的病态肥胖患者。使用2022年美国糖尿病协会指南标准通过2hPG定义糖尿病前期,而对于1hPG,血糖≥155mg/dL被视为糖尿病前期。采用Cohen's Kappa系数评估两种糖尿病前期诊断指标之间的一致性。
获得的Cohen's Kappa系数为0.405(p<0.001)。1hPG与胰岛素抵抗的稳态模型评估(HOMA-IR)呈正相关(ρ=0.281,p<0.001),与空腹血糖(FPG)呈正相关(ρ=0.581,p<0.001),与糖化血红蛋白(Hb1AC)呈正相关(ρ=0.347,p<0.001),与细胞β功能的稳态模型评估(HOMA-β)呈负相关(ρ=-0.092,p=0.018)。2hPG也与相同参数相关,但与HOMA-β无关。
证实了1hPG和2hPG之间有较好的一致性。1hPG标准可能是未诊断糖尿病的病态肥胖患者β细胞功能障碍和胰岛素抵抗的有用指标。